PMV Pharma director Matthew Joseph Eckler files initial beneficial ownership statement
PMVP•PMV Pharmaceuticals named Matthew Joseph Eckler as a director in an initial Form 3 filing dated Oct. 1, 2026.
1. Initial filing
PMV Pharmaceuticals named Matthew Joseph Eckler as a director in an initial Form 3 filing dated Oct. 1, 2026.
